<div id="readability-page-1"><div><p>Healthcare is among the worst-performing sectors as Wall Street starts December reversing Black Friday gains.</p><p>    Citius Oncology shares climbed after the company commercially launched its treatment Lymphir for patients with a rare type of cancer that affects the skin. </p><p>    Shares of vaccine makers fall as a FDA official's memo outlined a link between COVID-19 mRNA vaccines and myocarditis deaths in 10 children. </p><p>    Eli Lilly cut prices of its Zepbound drug single-dose vials on its direct-to-consumer platform after it lowered prices of its multi-dose pens last month. </p><p>   Write to Paulo Trevisani at paulo.trevisani@wsj.com </p><p>    (END) Dow Jones Newswires</p><p>12-01-25 1659ET</p></div></div>

禮來

CTOR

<p>醫療股表現不佳，華爾街逆轉了黑色星期五的漲幅。Citius Oncology 的股票在推出針對一種罕見皮膚癌的 Lymphir 後上漲。由於 FDA 的一份備忘錄將 COVID-19 mRNA 疫苗與兒童心肌炎死亡事件聯繫起來，疫苗製造商的股票下跌。禮來在其直接面向消費者的平台上降低了 Zepbound 藥瓶的價格</p>

醫療保健股票回吐了部分近期的漲幅 -- 醫療保健綜述